Results 131 to 140 of about 558,945 (252)

Circadian Lighting Was Associated with a Reduction in the Number of Hospitalized Patients Experiencing Falls: A Retrospective Observational Study. [PDF]

Healthcare (Basel)
Okinami T, Suzuki T, Nishikawa N, Negoro H.   +3 more
europepmc   +1 more source

Acute Postural Effects of Spinal Cord Injury: Dual Neural Opioid and Endocrine Non-Opioid Mechanism. [PDF]

Cells
Watanabe H, Lavrov I, Hallberg M, Schouenborg J, Zhang M, Bakalkin G.   +5 more
europepmc   +1 more source

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

Health Technol Assess
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, Evans BA, Fuller G, Hoskins R, Hughes J, Jones J, Jones M, Johnston S, Long J, Moore C, Parab R, Pilbery R, Sampson FC, Watkins A.   +18 more
europepmc   +1 more source

Finding new ways to treat overdoses. [PDF]

Elife
Turner JR, Martin J.
europepmc   +1 more source

Exploring disparities: a regional analysis of harm reduction supply distribution and opioid-related deaths across Ontario's Public Health Units. [PDF]

Harm Reduct J
Ledlie S, Scarfone K, Shearer D, Zurba N, Miskovic M, Munro C, Besharah J, Pinkerton S, Watts T, Gomes T.   +9 more
europepmc   +1 more source

Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression. [PDF]

J Pharmacol Exp Ther
Carr JA, Morgan DJ.
europepmc   +1 more source

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report. [PDF]

Addict Sci Clin Pract
Azar P, Machado J, Kim JJ, Wong JSH, Nikoo M, Li VW.   +5 more
europepmc   +1 more source

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. [PDF]

ACS Chem Neurosci
Oasa S, Mak WH, Maddox AL, Lima C, Saftics A, Terenius L, Jovanović-Talisman T, Vukojević V.   +7 more
europepmc   +1 more source

Validation of the naloxone cardiac arrest decision instrument for identifying opioid-associated cardiac arrests. [PDF]

Resuscitation
Dillon DG, Allan KS, Montoy JCC, Visanji M, Rodriguez RM, Lin S, Wang RC.   +6 more
europepmc   +1 more source

Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone. [PDF]

Arch Toxicol
Endt F, Guo T, Steinritz D, Amend N, Gudermann T, Breit A.   +5 more
europepmc   +1 more source